ACAD
38.17
+0.26
+0.69%
AEMD
7.05
-0.1
-1.40%
APRI
1.35
+0.12
+9.76%
ARNA
2.71
+0.06
+2.26%
ATEC
0.54
-0.03
-5.26%
CNAT
4.05
+0.37
+10.05%
CRXM
0.37
-0.02
-5.13%
CYTX
0.315
+0.016
+5.246%
DXCM
94.19
+0.45
+0.48%
GNMK
10.02
+0.59
+6.26%
HALO
18.41
+0.37
+2.05%
ILMN
201.7
-0.24
-0.12%
INNV
0.148
+0.003
+2.069%
INO
7.73
+0.75
+10.74%
ISCO
3.98
+0.33
+9.04%
ISIS
51.54
-0.02
-0.04%
LGND
95.04
+0.79
+0.84%
LPTN
0.225
+0.015
+7.092%
MBVX
1.685
-0.005
-0.296%
MEIP
1.73
+0.04
+2.37%
MNOV
2.94
-0.03
-1.01%
MRTX
26.66
+1.17
+4.59%
MSTX
0.47
+0.02
+3.96%
NBIX
46.67
+0.41
+0.89%
NUVA
53.75
+1
+1.90%
ONCS
5.2
+0.02
+0.48%
ONVO
2.54
+0.04
+1.60%
OREX
2.89
+0.13
+4.71%
OTIC
23.5
+0.12
+0.51%
QDEL
20.45
-0.25
-1.21%
RCPT
231.96
0.00
0.00%
RGLS
8.27
+0.79
+10.56%
RMD
52.47
+0.82
+1.59%
SCIE
0.015
+0.001
+3.5714%
SPHS
0.89
+0.03
+3.49%
SRNE
13.65
+0.33
+2.48%
TROV
6.33
+0.55
+9.52%
VICL
0.59
+0.03
+5.32%
VOLC
18
0.00
0.00%
ZGNX
18.41
+1.35
+7.91%
ACAD
38.17
+0.26
+0.69%
AEMD
7.05
-0.1
-1.40%
APRI
1.35
+0.12
+9.76%
ARNA
2.71
+0.06
+2.26%
ATEC
0.54
-0.03
-5.26%
CNAT
4.05
+0.37
+10.05%
CRXM
0.37
-0.02
-5.13%
CYTX
0.315
+0.016
+5.246%
DXCM
94.19
+0.45
+0.48%
GNMK
10.02
+0.59
+6.26%
HALO
18.41
+0.37
+2.05%
ILMN
201.7
-0.24
-0.12%
INNV
0.148
+0.003
+2.069%
INO
7.73
+0.75
+10.74%
ISCO
3.98
+0.33
+9.04%
ISIS
51.54
-0.02
-0.04%
LGND
95.04
+0.79
+0.84%
LPTN
0.225
+0.015
+7.092%
MBVX
1.685
-0.005
-0.296%
MEIP
1.73
+0.04
+2.37%
MNOV
2.94
-0.03
-1.01%
MRTX
26.66
+1.17
+4.59%
MSTX
0.47
+0.02
+3.96%
NBIX
46.67
+0.41
+0.89%
NUVA
53.75
+1
+1.90%
ONCS
5.2
+0.02
+0.48%
ONVO
2.54
+0.04
+1.60%
OREX
2.89
+0.13
+4.71%
OTIC
23.5
+0.12
+0.51%
QDEL
20.45
-0.25
-1.21%
RCPT
231.96
0.00
0.00%
RGLS
8.27
+0.79
+10.56%
RMD
52.47
+0.82
+1.59%
SCIE
0.015
+0.001
+3.5714%
SPHS
0.89
+0.03
+3.49%
SRNE
13.65
+0.33
+2.48%
TROV
6.33
+0.55
+9.52%
VICL
0.59
+0.03
+5.32%
VOLC
18
0.00
0.00%
ZGNX
18.41
+1.35
+7.91%
Home » Archive by Category

Xconomy

Summer Reading List: True Tales That Will Inspire and Educate You

June 1, 2015 – 3:05 am

OK, you’ve already read the latest hot science bestsellers—Siddhartha Mukherjee’s The Emperor of All Maladies and Rebecca Skloot’s The Immortal Life of Henrietta Lacks (both terrific, by the…

[[Click headline to continue reading.]]

Retrophin Turns Asklepion Voucher Into $245M Sanofi Payday

May 27, 2015 – 6:32 am

File this one under shrewd dealmaking: Less than three months after buying a small drugmaker in Baltimore, MD, Retrophin has already made its money back—and then some. New York- and San Diego,…

[[Click headline to continue reading.]]

After Orexigen Gaffe, What Role for Drugs Amid Obesity Crisis?

May 26, 2015 – 3:30 am

Two recent happenings prompted this column. First, Orexigen Therapeutics drew fire from, well, nearly everyone earlier this month for an improper release of data related to its weight-loss drug…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Illumina, Veracyte, Otonomy, Kite & More

May 22, 2015 – 10:00 am

Out west this week, the news flow was breezy. There were a sprinkling of diagnostics showers led by Illumina, which is in a patent fight with a Roche subsidiary, and Veracyte, which presented…

[[Click headline to continue reading.]]

Neuro Startup Challenge Winners Try To Commercialize NIH Inventions

May 21, 2015 – 11:39 am

The winning teams were announced today in the Neuro Startup Challenge, a two-year-old virtual accelerator that helps academic researchers and entrepreneurs build companies around promising…

[[Click headline to continue reading.]]

Companion Medical Raises $3M to Get Its Smart Insulin Pen to Market

May 20, 2015 – 9:58 pm

Companion Medical, a San Diego medical device startup founded about 16 months ago, has raised $3 million in an ongoing Series B financing round led by an investment from Eli Lilly, according to a…

[[Click headline to continue reading.]]

Companion Medical Raises $3M to Get Its Smart Insulin Pen to Market

May 20, 2015 – 9:58 pm

Companion Medical, a San Diego medical device startup founded about 16 months ago, has raised $3 million in an ongoing Series B financing round led by an investment from Eli Lilly, according to a…

[[Click headline to continue reading.]]

Celgene to Use Cypher Genomics’ Data Analytics in Drug Development

May 20, 2015 – 5:00 am

Under a collaboration announced today, San Diego-based Cypher Genomics said it would use its biomarker discovery service to help New Jersey’s Celgene (NASDAQ: CELG) identify key genetic variants…

[[Click headline to continue reading.]]

Celgene to Use Cypher Genomics’ Data Analytics in Drug Development

May 20, 2015 – 5:00 am

Under a collaboration announced today, San Diego-based Cypher Genomics said it would use its biomarker discovery service to help New Jersey’s Celgene (NASDAQ: CELG) identify key genetic variants…

[[Click headline to continue reading.]]

Fate Therapeutics, Riding High on Juno Deal, Raising More Cash

May 19, 2015 – 8:41 am

Taking advantage of a healthy bounce on Wall Street, San Diego’s Fate Therapeutics (NASDAQ: FATE) said Monday it plans to sell 6 million shares of its common stock through a secondary public…

[[Click headline to continue reading.]]